Skip to main content
Emerging Infectious Diseases logoLink to Emerging Infectious Diseases
. 2000 Mar-Apr;6(2):180–183. doi: 10.3201/eid0602.000212

Erythromycin resistance in Streptococcus pyogenes in Italy.

M Bassetti 1, G Manno 1, A Collidà 1, A Ferrando 1, G Gatti 1, E Ugolotti 1, M Cruciani 1, D Bassetti 1
PMCID: PMC2640849  PMID: 10756153

Abstract

In a prospective study of acute pharyngitis in Italian children, 69 (38.3%) of 180 isolates of Streptococcus pyogenes were resistant to macrolides. S. pyogenes was eradicated in 12 (63.1%) of 19 patients with erythromycin-resistant S. pyogenes treated with clarithromycin and in 22 (88%) of 25 patients with erythromycin-susceptible strains. The constitutive-resistant phenotype was correlated with failure of macrolide treatment.

Full Text

The Full Text of this article is available as a PDF (202.4 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bassetti M., Mantero E., Gatti G., Di Biagio A., Bassetti D. Streptococcus pyogenes erythromycin resistance in Italy. Emerg Infect Dis. 1999 Mar-Apr;5(2):302–303. doi: 10.3201/eid0502.990223. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Bisno A. L. Group A streptococcal infections and acute rheumatic fever. N Engl J Med. 1991 Sep 12;325(11):783–793. doi: 10.1056/NEJM199109123251106. [DOI] [PubMed] [Google Scholar]
  3. Cocuzza C., Blandino G., Mattina R., Nicoletti F., Nicoletti G. Antibiotic susceptibility of group A streptococci in 2 Italian cities: Milano and Catania. Microb Drug Resist. 1997 Winter;3(4):379–384. doi: 10.1089/mdr.1997.3.379. [DOI] [PubMed] [Google Scholar]
  4. Cornaglia G., Ligozzi M., Mazzariol A., Masala L., Lo Cascio G., Orefici G., Fontana R. Resistance of Streptococcus pyogenes to erythromycin and related antibiotics in Italy. The Italian Surveillance Group for Antimicrobial Resistance. Clin Infect Dis. 1998 Aug;27 (Suppl 1):S87–S92. doi: 10.1086/514908. [DOI] [PubMed] [Google Scholar]
  5. Cornaglia G., Ligozzi M., Mazzariol A., Valentini M., Orefici G., Fontana R. Rapid increase of resistance to erythromycin and clindamycin in Streptococcus pyogenes in Italy, 1993-1995. The Italian Surveillance Group for Antimicrobial Resistance. Emerg Infect Dis. 1996 Oct-Dec;2(4):339–342. doi: 10.3201/eid0204.960410. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Garcia-Bermejo I., Cacho J., Orden B., Alós J. I., Gómez-Garcés J. L. Emergence of erythromycin-resistant, clindamycin-susceptible Streptococcus pyogenes isolates in Madrid, Spain. Antimicrob Agents Chemother. 1998 Apr;42(4):989–990. doi: 10.1128/aac.42.4.989. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Hsueh P. R., Chen H. M., Huang A. H., Wu J. J. Decreased activity of erythromycin against Streptococcus pyogenes in Taiwan. Antimicrob Agents Chemother. 1995 Oct;39(10):2239–2242. doi: 10.1128/aac.39.10.2239. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Kaplan E. L. The resurgence of group A streptococcal infections and their sequelae. Eur J Clin Microbiol Infect Dis. 1991 Feb;10(2):55–57. doi: 10.1007/BF01964407. [DOI] [PubMed] [Google Scholar]
  9. LOWBURY E. J., HURST L. The sensitivity of staphylococci and other wound bacteria to erythromycin, oleandomycin, and spiramycin. J Clin Pathol. 1959 Mar;12(2):163–169. doi: 10.1136/jcp.12.2.163. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Moses A. E., Ziv A., Harari M., Rahav G., Shapiro M., Englehard D. Increased incidence and severity of Streptococcus pyogenes bacteremia in young children. Pediatr Infect Dis J. 1995 Sep;14(9):767–770. doi: 10.1097/00006454-199509000-00007. [DOI] [PubMed] [Google Scholar]
  11. Orden B., Perez-Trallero E., Montes M., Martínez R. Erythromycin resistance of Streptococcus pyogenes in Madrid. Pediatr Infect Dis J. 1998 Jun;17(6):470–473. doi: 10.1097/00006454-199806000-00006. [DOI] [PubMed] [Google Scholar]
  12. Peter G. Streptococcal pharyngitis: current therapy and criteria for evaluation of new agents. Clin Infect Dis. 1992 Jun;14 (Suppl 2):S218–S232. doi: 10.1093/clinids/14.supplement_2.s218. [DOI] [PubMed] [Google Scholar]
  13. Phillips G., Parratt D., Orange G. V., Harper I., McEwan H., Young N. Erythromycin-resistant Streptococcus pyogenes. J Antimicrob Chemother. 1990 Apr;25(4):723–724. doi: 10.1093/jac/25.4.723. [DOI] [PubMed] [Google Scholar]
  14. Sanders E., Foster M. T., Scott D. Group A beta-hemolytic streptococci resistant to erythromycin and lincomycin. N Engl J Med. 1968 Mar 7;278(10):538–540. doi: 10.1056/NEJM196803072781005. [DOI] [PubMed] [Google Scholar]
  15. Schito G. C., Pesce A., Marchese A. The role of macrolides in Streptococcus pyogenes pharyngitis. J Antimicrob Chemother. 1997 May;39(5):562–565. doi: 10.1093/jac/39.5.562. [DOI] [PubMed] [Google Scholar]
  16. Seppälä H., Nissinen A., Järvinen H., Huovinen S., Henriksson T., Herva E., Holm S. E., Jahkola M., Katila M. L., Klaukka T. Resistance to erythromycin in group A streptococci. N Engl J Med. 1992 Jan 30;326(5):292–297. doi: 10.1056/NEJM199201303260503. [DOI] [PubMed] [Google Scholar]
  17. Seppälä H., Nissinen A., Yu Q., Huovinen P. Three different phenotypes of erythromycin-resistant Streptococcus pyogenes in Finland. J Antimicrob Chemother. 1993 Dec;32(6):885–891. doi: 10.1093/jac/32.6.885. [DOI] [PubMed] [Google Scholar]
  18. Stingemore N., Francis G. R., Toohey M., McGechie D. B. The emergence of erythromycin resistance in Streptococcus pyogenes in Fremantle, Western Australia. Med J Aust. 1989 Jun 5;150(11):626-7, 630-1. doi: 10.5694/j.1326-5377.1989.tb136725.x. [DOI] [PubMed] [Google Scholar]
  19. Sutcliffe J., Tait-Kamradt A., Wondrack L. Streptococcus pneumoniae and Streptococcus pyogenes resistant to macrolides but sensitive to clindamycin: a common resistance pattern mediated by an efflux system. Antimicrob Agents Chemother. 1996 Aug;40(8):1817–1824. doi: 10.1128/aac.40.8.1817. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Emerging Infectious Diseases are provided here courtesy of Centers for Disease Control and Prevention

RESOURCES